Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Effects of plaque composition on vascular remodelling after angioplasty in the MultiVitamins and Probucol (MVP) trial.

Lee HS, Tardif JC, Harel F, Côté G, Joyal M, Gosselin G, L'Allier PL, Doucet S, de Guise P, Lespérance J, Grégoire JC, Couturier A.

Can J Cardiol. 2002 Mar;18(3):271-5.

PMID:
11907616
2.

Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group.

Côté G, Tardif JC, Lespérance J, Lambert J, Bourassa M, Bonan R, Gosselin G, Joyal M, Tanguay JF, Nattel S, Gallo R, Crépeau J.

Circulation. 1999 Jan 5-12;99(1):30-5.

3.

Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.

Tardif JC, Côté G, Lespérance J, Gosselin G, Joyal M, de Guise P, Bilodeau L, Doucet S, Harel F, Couturier A, Gallo R, Grégoire J.

Can J Cardiol. 2001 Jan;17(1):49-55.

PMID:
11173314
4.

Prevention of restenosis after angioplasty in small coronary arteries with probucol.

Rodés J, Côté G, Lespérance J, Bourassa MG, Doucet S, Bilodeau L, Bertrand OF, Harel F, Gallo R, Tardif JC.

Circulation. 1998 Feb 10;97(5):429-36.

5.

Prevention of restenosis with antioxidants: mechanisms and implications.

Tardif JC, Grégoire J, L'Allier PL.

Am J Cardiovasc Drugs. 2002;2(5):323-34. Review.

PMID:
14727962
6.

Combination balloon-ultrasound imaging catheter for percutaneous transluminal angioplasty. Validation of imaging, analysis of recoil, and identification of plaque fracture.

Isner JM, Rosenfield K, Losordo DW, Rose L, Langevin RE Jr, Razvi S, Kosowsky BD.

Circulation. 1991 Aug;84(2):739-54.

PMID:
1860219
7.

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.

Jay SJ.

N Engl J Med. 1997 Dec 25;337(26):1918-9; author reply 1919. No abstract available.

PMID:
9417526
8.

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.

Tardif JC, Cöté G, Lespérance J, Bourassa M, Lambert J, Doucet S, Bilodeau L, Nattel S, de Guise P.

N Engl J Med. 1997 Aug 7;337(6):365-72.

9.

Intravascular Ultrasound Assessment of the Mechanisms and Predictors of Restenosis Following Coronary Angioplasty.

Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Hong MK, Leon MB.

J Invasive Cardiol. 1996 Jan;8(1):1-14.

PMID:
10785680
10.

Intravascular Ultrasound Assessment of the Mechanisms and Predictors of Restenosis Following Coronary Angioplasty.

Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Hong MK, Leon MB.

J Invasive Cardiol. 1997 May;9(4):303-314.

PMID:
10762918
11.

Residual plaque burden, delivered dose, and tissue composition predict 6-month outcome after balloon angioplasty and beta-radiation therapy.

Sabaté M, Marijnissen JP, Carlier SG, Kay IP, van der Giessen WJ, Coen VL, Ligthart JM, Boersma E, Costa MA, Levendag PC, Serruys PW.

Circulation. 2000 May 30;101(21):2472-7.

12.

Low daily dose of antioxidant probucol decreases incidence and severity of restenosis after transluminal coronary balloon angioplasty.

Kaminnyi AI, Lankin VZ, Samko AN, Sozykin AL, Provatorov SI, Konovalova GG, Perepelitsa EI, Tikhaze AK, Polevaya TY, Kukharchuk VV, Belenkov YN.

Bull Exp Biol Med. 2005 Feb;139(2):183-5. English, Russian.

PMID:
16027801
13.

Intravascular ultrasound-guided balloon angioplasty compared with stent: immediate and 6-month results of the multicenter, randomized Balloon Equivalent to Stent Study (BEST).

Schiele F, Meneveau N, Gilard M, Boschat J, Commeau P, Ming LP, Sewoke P, Seronde MF, Mercier M, Gupta S, Bassand JP; Balloon Equivalent to Stent Study..

Circulation. 2003 Feb 4;107(4):545-51.

14.

Effects of AGI-1067 and probucol after percutaneous coronary interventions.

Tardif JC, Grégoire J, Schwartz L, Title L, Laramée L, Reeves F, Lespérance J, Bourassa MG, L'Allier PL, Glass M, Lambert J, Guertin MC; Canadian Antioxidant Restenosis Trial (CART-1) Investigators..

Circulation. 2003 Feb 4;107(4):552-8.

15.

Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.

Yokoi H, Daida H, Kuwabara Y, Nishikawa H, Takatsu F, Tomihara H, Nakata Y, Kutsumi Y, Ohshima S, Nishiyama S, Seki A, Kato K, Nishimura S, Kanoh T, Yamaguchi H.

J Am Coll Cardiol. 1997 Oct;30(4):855-62.

16.

Clinical results with AGI-1067: a novel antioxidant vascular protectant.

Tardif JC.

Am J Cardiol. 2003 Feb 6;91(3A):41A-49A. Review.

PMID:
12645643
17.

Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]).

Daida H, Kuwabara Y, Yokoi H, Nishikawa H, Takatsu F, Nakata Y, Kutsumi Y, Oshima S, Nishiyama S, Ishiwata S, Kato K, Nishimura S, Miyauchi K, Kanoh T, Yamaguchi H.

Am J Cardiol. 2000 Sep 1;86(5):550-2, A9.

PMID:
11009277
18.

Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.

Tardif JC, Grégoire J, Lavoie MA, L'Allier PL.

Curr Opin Lipidol. 2003 Dec;14(6):615-20. Review.

PMID:
14624139
19.

Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT).

Hedman M, Hartikainen J, Syvänne M, Stjernvall J, Hedman A, Kivelä A, Vanninen E, Mussalo H, Kauppila E, Simula S, Närvänen O, Rantala A, Peuhkurinen K, Nieminen MS, Laakso M, Ylä-Herttuala S.

Circulation. 2003 Jun 3;107(21):2677-83.

20.

Intravascular ultrasound imaging before and after angioplasty for stenosis of arteriovenous fistulae in haemodialysis patients.

Higuchi T, Okuda N, Aoki K, Ishii Y, Matsumoto H, Ohnishi Y, Hagi C, Kikuchi F, Okada K, Kuno T, Honye J, Saito S, Nagura Y, Takahashi S, Kanmatsuse K.

Nephrol Dial Transplant. 2001 Jan;16(1):151-5.

Items per page

Supplemental Content

Support Center